← All stocks

ResMed|

RMD Net selling
CIK 0000943819 #393 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$372.20M
$19.33M on a plan · $254.50M straight out of an exercise
Sold at will
$98.37M
206 of 541 sales
Net
−$372.20M
−$98.37M against sales at will

By person

27 insiders · 554 transactions
85.8×

Michael Farrell holds 85.8 times base salary in stock. $104.18M of shares against $1.21M in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Farrell last reported holding, valued at $222.44, the price ResMed Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Farrell Michael J.
Chairman and CEO
$98.00M (75) scheduled
−$98.00M
468,346
0.3247%
$104.18M
+132.0%
Sandercock Brett
Chief Financial Officer
$50.57M (99)
−$50.57M
83,495
0.0579%
$18.57M
+21.9%
FARRELL PETER C
Director
$46.50M (43) scheduled
−$46.50M
51,803
0.0359%
$11.52M
−85.1%
Douglas Robert Andrew
Special Advisor
$44.71M (66) scheduled
−$44.71M
264,375
0.1833%
$58.81M
+138.0%
PENDARVIS DAVID
Chief Administrative Officer
$37.50M (82) scheduled
−$37.50M
89,729
0.0622%
$19.96M
+9.6%
Hollingshead James
President, Sleep Business
$19.86M (70)
−$19.86M
76,721
0.0532%
$17.07M
+53.0%
Leong Justin
Chief Product Officer
$14.42M (4)
−$14.42M
29,028
0.0201%
$6.46M
+16.9%
WAREHAM JOHN P
Director
$12.77M (9) scheduled
−$12.77M
11,300
0.0078%
$2.51M
−13.1%
Ghoshal Kaushik
Chief Commercial Officer, SaaS
$10.05M (14) scheduled
−$10.05M
19,353
0.0134%
$4.30M
+149.3%
SULPIZIO RICHARD
Director
$9.85M (3)
−$9.85M
17,796
0.0123%
$3.96M
−86.6%
Sodhi Rajwant
President, SaaS Business
$8.57M (26)
−$8.57M
26,731
0.0185%
$5.95M
+13.7%
McHale Richard
President, RC Business
$5.84M (9) scheduled
−$5.84M
22,982
0.0159%
$5.11M
+114.5%
PACE GARY W
Director
$4.62M (3) scheduled
−$4.62M
100,578
0.0697%
$22.37M
+8.0%
Burt Carol
Director
$2.36M (3)
−$2.36M
17,048
0.0118%
$3.79M
+36.9%
TAYLOR RONALD R
Director
$1.89M (3)
−$1.89M
24,771
0.0172%
$5.51M
+28.9%
ROBERTS CHRISTOPHER G
Retired Director
$1.80M (2)
−$1.80M
523,237
0.3627%
$116.39M
+20.7%
De Witte Jan
Director
$1.41M (5) scheduled
−$1.41M
4,261
0.0030%
$947.81K
+203.0%
Hernandez John
Director
$739.29K (1) scheduled
−$739.29K
5,118
0.0035%
$1.14M
+435.4%
Rider Michael J
Global General Counsel
$478.25K (21) scheduled
−$478.25K
9,488
0.0066%
$2.11M
+69.6%
Drexler Karen
Director
$225.93K (2)
−$225.93K
10,602
0.0073%
$2.36M
+254.5%
BLAISE LUCILE
President, Sleep & RC Business
$38.06K (1) scheduled
−$38.06K
10,305
0.0071%
$2.29M
+55.5%
Reiser Anne
President - ResMed Europe
84,429
0.0585%
$18.78M
−7.2%
RESMED INC entity
Director
13,823
0.0096%
$3.07M
+7.4%
Gill Harjit
Director
10,940
0.0076%
$2.43M
+331.9%
Tan Desney
Director
6,002
0.0042%
$1.34M
+527.8%
DelOrefice Christopher
Director
2,423
0.0017%
$538.97K
Mowad-Nassar Nicole
Director
777
0.0005%
$172.83K
Insider
Date
Role
Action
Shares
Price
Amount
FARRELL PETER C
14 Nov 2025
Director
Exercised, kept
11,442
$101.64
$1.16M
PENDARVIS DAVID
25 Nov 2022
Chief Administrative Officer
Exercised, kept
683
$146.34
$99.95K
PENDARVIS DAVID
11 Nov 2021
Chief Administrative Officer
Exercised, kept
983
$101.64
$99.91K
Showing 250 of 554 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 823
Amendments (4/A) skipped 17
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 72
Sales straight out of an exercise 263
Sales at will 206
Transactions with no price 0
Shares from compensation/vesting 5,338,212
Sales filed before the plan box existed 193
History held since 8 Sep 2016